Holen Sie sich die Stockscreener-App
34.50
1.43%
-0.50
Handel nachbörslich:
34.50
Collegium Pharmaceutical Inc Aktie (COLL) Neueste Nachrichten
Insider Sell: David Dieter Sells Shares of Collegium Pharmaceuti - GuruFocus
Risk Recap: What is the dividend yield of Collegium Pharmaceutical IncIndex Update & Weekly Setup with ROI Potential - baoquankhu1.vn
Collegium Pharmaceutical at Barclays Conference: Strategic Growth and Challenges By Investing.com - Investing.com Canada
WINTON GROUP Ltd Purchases Shares of 65,345 Collegium Pharmaceutical, Inc. $COLL - MarketBeat
Victory Capital Management Inc. Cuts Stock Position in Collegium Pharmaceutical, Inc. $COLL - MarketBeat
Collegium Pharmaceutical (COLL) Surged Following Record Quarterly Results - Yahoo Finance
Jefferies Financial Group Inc. Takes $4.43 Million Position in Collegium Pharmaceutical, Inc. $COLL - MarketBeat
Assessing Collegium Pharmaceutical (COLL) Valuation After Recent Share Price Weakness - simplywall.st
Market Catalysts: Can Collegium Pharmaceutical Inc be the next market leaderMarket Movers & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Collegium Pharmaceutical, Inc. (COLL) gains momentum on Jornay PM, Truist highlights robust pain portfolio - MSN
Dow Update: Will Collegium Pharmaceutical Inc benefit from green energy policiesTrade Volume Report & Smart Money Movement Alerts - baoquankhu1.vn
(COLL) Volatility Zones as Tactical Triggers - Stock Traders Daily
Pharma News: Can Collegium Pharmaceutical Inc benefit from deglobalizationQuarterly Market Summary & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Citigroup Inc. Decreases Stock Holdings in Collegium Pharmaceutical, Inc. $COLL - MarketBeat
Insider Sell: Scott Dreyer Sells 49,976 Shares of Collegium Phar - GuruFocus
Scott Dreyer Sells 49,976 Shares of Collegium Pharmaceutical (NASDAQ:COLL) Stock - MarketBeat
Collegium to Present New Real-World Data at PainConnect 2026 - The Manila Times
Quantbot Technologies LP Has $1.79 Million Position in Collegium Pharmaceutical, Inc. $COLL - MarketBeat
Collegium enrolls Paris Hilton in Jornay PM push encouraging ADHD community to 'Embrace Your Sparkle' - Fierce Pharma
49,976 COLL shares flagged for sale (NASDAQ: COLL) - Stock Titan
Collegium, Paris Hilton announce ‘Embrace Your Sparkle’ campaign - TipRanks
Paris Hilton Shares Her Experience with JORNAY PM and Launches New 'Embrace Your Sparkle' Campaign with Collegium to Empower the ADHD Community - ChartMill
Collegium Pharmaceutical Faces Weak Start with 8.74% Gap Down Amid Market Concerns - Markets Mojo
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Momentum Shift: Does Collegium Pharmaceutical Inc offer margin of safety2025 Pullback Review & Weekly High Return Stock Forecasts - baoquankhu1.vn
Can Collegium Pharmaceutical Inc be the next market leaderMarket Growth Report & Reliable Price Breakout Signals - baoquankhu1.vn
Collegium to Participate in Upcoming Investor Conferences - The Manila Times
Collegium Pharmaceutical plans four Miami investor events in March - Stock Titan
Aug EndMonth: What are analysts price targets for Collegium Pharmaceutical IncShort Setup & Growth Oriented Trading Recommendations - baoquankhu1.vn
Collegium Pharmaceutical, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:COLL) 2026-03-01 - Seeking Alpha
A Look At Collegium Pharmaceutical (COLL) Valuation After Mixed Q4 2025 Results And Updated 2026 Guidance - simplywall.st
Collegium Pharmaceutical (NASDAQ:COLL) Lowered to Buy Rating by Wall Street Zen - MarketBeat
Why Collegium Pharmaceutical (COLL) Is Down 7.4% After Reaffirming 2026 Revenue Guidance Despite Earnings Miss - Yahoo Finance
Why Collegium Pharmaceutical (COLL) Stock Is Trading Lower Today - Finviz
Analysts Have Conflicting Sentiments on These Healthcare Companies: Collegium Pharmaceutical (COLL) and Intellia Therapeutics (NTLA) - The Globe and Mail
Relative Strength Alert For Collegium Pharmaceutical - Nasdaq
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q4 2025 Earnings Call Transcript - Insider Monkey
Collegium (COLL) Q4 2025 Earnings Call Transcript - AOL.com
Collegium Pharmaceutical (COLL) Margin Compression To 8.1% Tests Bullish Profitability Narrative - simplywall.st
Collegium Pharmaceutical Earnings Call: Jornay Leads Growth - TipRanks
Collegium Pharmaceutical reports Q4 adjusted EPS $2.04, consensus $2.14 - TipRanks
Collegium Pharmaceutical (NASDAQ:COLL) Announces Quarterly Earnings Results, Misses Expectations By $0.16 EPS - MarketBeat
Collegium Pharmaceutical: Q4 Earnings Snapshot - theheraldreview.com
Collegium Pharmaceutical, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Deep Dive Into Collegium Pharmaceutical Stock: Analyst Perspectives (5 Ratings) - Benzinga
Collegium Pharmaceutical (NASDAQ:COLL) Price Target Lowered to $54.00 at Needham & Company LLC - MarketBeat
Collegium Pharmaceutical (COLL) Reports Q4 Earnings: What Key Metrics Have to Say - Yahoo Finance
Collegium Pharmaceutical (COLL) Q4 Earnings and Revenues Miss Estimates - Nasdaq
Earnings call transcript: Collegium Pharmaceutical Q4 2025 misses EPS forecast - Investing.com Nigeria
Collegium Pharmaceutical (NASDAQ:COLL) Shares Gap Down on Disappointing Earnings - MarketBeat
Collegium Pharmaceutical Q4 Adjusted Earnings, Net Product Revenue Rise - marketscreener.com
Collegium Pharmaceutical Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Collegium Pharmaceutical Q4 Earnings Call Highlights - Yahoo Finance
Collegium Pharmaceutical earnings missed by $0.10, revenue fell short of estimates - Investing.com UK
COLLEGIUM PHARMACEUTICAL ($COLL) Releases Q4 2025 Earnings - Quiver Quantitative
Collegium Pharmaceutical, Inc. Reaffirms Earnings Guidance for Full Year 2026 - marketscreener.com
Earnings Flash (COLL) Collegium Pharmaceutical, Inc. Reports Q4 Revenue $205.4M, vs. FactSet Est of $206.4M - marketscreener.com
Earnings Flash (COLL) Collegium Pharmaceutical, Inc. Posts Q4 Adjusted EPS $2.04 per Share, vs. FactSet Est of $2.14 - marketscreener.com
Collegium Pharmaceutical: Fourth Quarter Financial Overview - Bitget
Collegium Reports Record 2025 Results and Reaffirms Outlook - TipRanks
Collegium Pharmaceutical’s (NASDAQ:COLL) Q4 CY2025 Earnings Results: Revenue In Line With Expectations - Yahoo Finance
COLLEGIUM PHARMACEUTICAL, INC SEC 10-K Report - TradingView
Collegium (NASDAQ: COLL) outlines opioid, ADHD growth and rising generic threats - Stock Titan
Collegium (Nasdaq: COLL) posts record 2025 revenue and EBITDA - Stock Titan
1.15%
3.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):